Jeanette Broering, RN, PhD, MPH

Title(s)Academic Program Manager, Surgery
SchoolSchool of Medicine
Address550 16th Street, #5100
San Francisco CA 94158
Phone415-514-0203
ORCID ORCID Icon0000-0002-7580-8931 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Saint Louis University, St. Louis, MOBSN05/1974Nursing
    University of California, San Francisco, San Francisco, CAMS06/1985Nursing
    University of California, Berkeley, Berkley, CAMPH05/1992Epidemiology / Biostatistics
    University of California, San Francisco, San Francisco, CAPhD06/2012Nursing / Health Policy
    Veterans Administration Quality Scholar (VAQS) Fellowship , San Francisco, CAPost-doctoral Fellowship06/2014Quality Improvement / Patient Safety
    University of California , San Francisco, CA2022Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer. Cancer. 2024 Jan 27. Braun AE, Chan JM, Neuhaus J, Cowan JE, Kenfield SA, Van Blarigan EL, Tenggara I, Broering JM, Simko JP, Carroll PR, Cooperberg MR. PMID: 38280206.
      View in: PubMed   Mentions:    Fields:    
    2. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Eur Urol. 2023 Oct 17. Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR. PMID: 37858454.
      View in: PubMed   Mentions: 1     Fields:    
    3. Ten-year work burden after prostate cancer treatment. Cancer Med. 2023 Sep; 12(18):19234-19244. Washington SL, Lonergan PE, Cowan JE, Zhao S, Broering JM, Palmer NR, Hicks C, Cooperberg MR, Carroll PR. PMID: 37724617; PMCID: PMC10557888.
      View in: PubMed   Mentions: 1     Fields:    
    4. Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer. Urol Oncol. 2023 10; 41(10):429.e9-429.e14. Baskin A, Cowan JE, Braun A, Lonergan PE, Mohamad O, Washington SL, Zhao S, Broering JM, Cooperberg MR, Breyer BN, Carroll PR. PMID: 37407420.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer. Urology. 2023 Aug; 178:114-119. Lonergan PE, Baskin A, Greenberg SA, Mohamad O, Washington SL, Zhao S, Cowan JE, Broering JM, Nguyen HG, Cooperberg MR, Breyer BN, Carroll PR. PMID: 37244430.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality. Br J Cancer. 2023 08; 129(2):346-355. Langlais CS, Graff RE, Van Blarigan EL, Neuhaus JM, Cowan JE, Broering JM, Carroll P, Kenfield SA, Chan JM. PMID: 37217583; PMCID: PMC10338438.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula. Eur J Epidemiol. 2022 Oct 26. Smith LH, García-Albéniz X, Chan JM, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR, Hernán MA. PMID: 36289138.
      View in: PubMed   Mentions:    Fields:    
    8. Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence. Eur J Cancer Care (Engl). 2022 Nov; 31(6):e13740. Weng X, Zhong L, Xiang P, Li Y, Paciorek A, Dong L, Broering J, Carroll PR, Sanda M, Wilson L. PMID: 36239065.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. See one, do one, teach one: a flipped classroom to make quality improvement experiential in surgical residency. Global Surgical Education - Journal of the Association for Surgical Education. 2022; 1(1):36. Bongiovanni, T., Lancaster, E., Decker, H., Mukhtar, R. A., Schwab, M., Broering, J., O’Sullivan, P., Hirose, K., & Wick, E. View Publication.
    10. Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality. Cancer Epidemiol Biomarkers Prev. 2022 09 02; 31(9):1760-1768. Langlais CS, Graff RE, Van Blarigan EL, Kenfield SA, Neuhaus J, Tabung FK, Cowan JE, Broering JM, Carroll P, Chan JM. PMID: 35767977; PMCID: PMC9444922.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer. J Urol. 2022 04; 207(4):832-840. Lonergan PE, Washington SL, Cowan JE, Zhao S, Broering JM, Cooperberg MR, Carroll PR. PMID: 34854749.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history. Cancer Causes Control. 2021 Jun; 32(6):635-644. Langlais CS, Chan JM, Kenfield SA, Cowan JE, Graff RE, Broering JM, Carroll P, Van Blarigan EL. PMID: 33837499; PMCID: PMC8189293.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Patient Perceptions on Barriers and Facilitators to Accessing Low-acuity Surgery During COVID-19 Pandemic. J Surg Res. 2021 08; 264:30-36. Johnson CL, Schwartz H, Greenberg A, Hernandez S, Nnamani Silva ON, Wong LE, Martins DB, Broering JM, Kumar SB, Bongiovanni T, Wick EC, Roman SA. PMID: 33744775; PMCID: PMC7867400.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    14. Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial. J Med Internet Res. 2020 12 31; 22(12):e19238. Chan JM, Van Blarigan EL, Langlais CS, Zhao S, Ramsdill JW, Daniel K, Macaire G, Wang E, Paich K, Kessler ER, Beer TM, Lyons KS, Broering JM, Carroll PR, Kenfield SA, Winters-Stone KM. PMID: 33382378; PMCID: PMC7808895.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    15. Web-Based Lifestyle Interventions for Prostate Cancer Survivors: Qualitative Study. JMIR Cancer. 2020 Nov 10; 6(2):e19362. Wang EY, Graff RE, Chan JM, Langlais CS, Broering JM, Ramsdill JW, Kessler ER, Winters-Stone KM, Van Blarigan EL, Kenfield SA. PMID: 33170126; PMCID: PMC7685923.
      View in: PubMed   Mentions: 6  
    16. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry. Urol Oncol. 2020 10; 38(10):793.e1-793.e11. Borno HT, Cowan JE, Zhao S, Broering JM, Carroll PR, Ryan CJ. PMID: 32782182.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer. JNCI Cancer Spectr. 2020 Oct; 4(5):pkaa044. Jeong CW, Herlemann A, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR. PMID: 33134826; PMCID: PMC7583149.
      View in: PubMed   Mentions:    Fields:    
    18. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients. Cancer Med. 2020 01; 9(1):125-132. Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR. PMID: 31714037; PMCID: PMC6943165.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    19. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry. Clin Genitourin Cancer. 2020 02; 18(1):e21-e27. Ten Ham RMT, Broering JM, Cooperberg MR, Carroll P, Wilson LS. PMID: 31796344.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer. J Urol. 2019 10; 202(4):689-695. Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM. PMID: 31091175; PMCID: PMC7017721.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    21. Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1917-1925. Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM. PMID: 31462398; PMCID: PMC6825577.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    22. What Matters? The Valued Life Activities of Older Adults Undergoing Elective Surgery. J Am Geriatr Soc. 2019 11; 67(11):2305-2310. Kata A, Dutt M, Sudore RL, Finlayson E, Broering JM, Tang VL. PMID: 31400227; PMCID: PMC6910083.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    23. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry. Eur Urol. 2019 12; 76(6):743-751. Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR. PMID: 31345635.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 2019 Sep; 131:157-165. Balakrishnan AS, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR. PMID: 31150694.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Nov 15; 7(11):e11257. Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM. PMID: 30442638; PMCID: PMC6265599.
      View in: PubMed   Mentions: 5  
    26. Increasing Advance Care Planning Using a Surgical Optimization Program for Older Adults. J Am Geriatr Soc. 2018 10; 66(10):2017-2021. Kata A, Sudore R, Finlayson E, Broering JM, Ngo S, Tang VL. PMID: 30289968; PMCID: PMC6181775.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    27. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment. Prostate Cancer Prostatic Dis. 2019 03; 22(1):117-124. Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR. PMID: 30171230.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™). Prostate. 2018 Jan; 78(1):32-39. Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM. PMID: 29105845; PMCID: PMC5716878.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    29. Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments. J Urol. 2017 09; 198(3):671-677. Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR. PMID: 28342935; PMCID: PMC5636214.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    30. Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test. Value Health. 2014 Nov; 17(7):A651. Ten Ham RM, Wilson LS, Broering JM, Cooperberg MR, Carroll P. PMID: 27202352.
      View in: PubMed   Mentions:    Fields:    
    31. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments. Qual Life Res. 2014 Mar; 23(2):495-508. Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C. PMID: 23943258.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    32. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer. 2010 Nov 15; 116(22):5226-34. Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. PMID: 20690197; PMCID: PMC2975879.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    33. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010 Mar 01; 28(7):1117-23. Cooperberg MR, Broering JM, Carroll PR. PMID: 20124165; PMCID: PMC2834465.
      View in: PubMed   Mentions: 393     Fields:    Translation:Humans
    34. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010 Mar; 91(3):712-21. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. PMID: 20042525; PMCID: PMC3132069.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    35. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol. 2009 Sep 10; 27(26):4306-13. Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H. PMID: 19667269; PMCID: PMC2744272.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    36. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst. 2009 Jun 16; 101(12):878-87. Cooperberg MR, Broering JM, Carroll PR. PMID: 19509351; PMCID: PMC2697208.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    37. High-risk prostate cancer in the United States, 1990-2007. World J Urol. 2008 Jun; 26(3):211-8. Cooperberg MR, Cowan J, Broering JM, Carroll PR. PMID: 18369637; PMCID: PMC2948572.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    38. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007 Sep; 178(3 Pt 2):S14-9. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR. PMID: 17644125; PMCID: PMC2987559.
      View in: PubMed   Mentions: 155     Fields:    Translation:Humans
    39. Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice. Cancer. 2007 May 01; 109(9):1777-83. Litwin MS, Greenfield S, Elkin EP, Lubeck DP, Broering JM, Kaplan SH. PMID: 17354226.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    40. Cumulative cost pattern comparison of prostate cancer treatments. Cancer. 2007 Feb 01; 109(3):518-27. Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR. PMID: 17186528.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    41. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE. J Urol. 2006 Apr; 175(4):1326-31. Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll PR. PMID: 16515991.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    42. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005 Dec; 66(6):1223-8. Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. PMID: 16360447.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    43. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet. 2004 Nov 6-12; 364(9446):1678-83. Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, Miller S, Canjura-Clayton KL, Farhat S, Broering JM, Darragh TM. PMID: 15530628.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    44. Patterns of practice in the United States: insights from CaPSURE on prostate cancer management. Curr Urol Rep. 2004 Jun; 5(3):166-72. Cooperberg MR, Broering JM, Latini DM, Litwin MS, Wallace KL, Carroll PR. PMID: 15161564.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    45. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol. 2004 Apr; 171(4):1393-401. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR, CaPSURE Investigators. PMID: 15017184.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    46. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol. 2002 Aug; 168(2):530-5. Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR. PMID: 12131303.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    47. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology. 2002 Apr; 59(4):560-5. Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR. PMID: 11927314.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    48. Patient satisfaction with oral versus nonoral therapeutic approaches in onychomycosis. J Am Podiatr Med Assoc. 2001 Nov-Dec; 91(10):521-7. Stier DM, Gause D, Joseph WS, Schein JR, Broering JM, Warolin KL, Doyle JJ. PMID: 11734608.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    49. Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy. Urology. 2001 Aug; 58(2 Suppl 1):56-64. Grossfeld GD, Small EJ, Lubeck DP, Latini D, Broering JM, Carroll PR. PMID: 11502450.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001 Jun 20; 285(23):2995-3002. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J. PMID: 11410098.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansCells
    51. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol. 2001 Mar; 165(3):851-6. Grossfeld GD, Chang JJ, Broering JM, Li YP, Lubeck DP, Flanders SC, Carroll PR. PMID: 11176485.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    52. Cost of treatment for onychomycosis. Data from a 9-month observational study. Pharmacoeconomics. 2001; 19(3):267-79. Stier DM, Henke C, Schein J, Doyle J, Schonfeld WH, Broering J. PMID: 11303415.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database. Urology. 2000 Sep 01; 56(3):430-5. Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Carroll PR. PMID: 10962308.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor. J Urol. 2000 Jul; 164(1):81-8. Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, Carroll PR. PMID: 10840429.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    55. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. J Urol. 2000 Apr; 163(4):1171-7; quiz 1295. Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Henning JM, Stier DM, Carroll PR. PMID: 10737489.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    56. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998 Feb; 132(2):277-84. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, Palefsky J. PMID: 9506641.
      View in: PubMed   Mentions: 127     Fields:    Translation:HumansCells
    57. Female adolescents at high, moderate, and low risk of exposure to HIV: differences in knowledge, beliefs, and behavior. J Adolesc Health. 1994 Mar; 15(2):133-41. Millstein SG, Moscicki AB, Broering JM. PMID: 8018686.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Risks of human immunodeficiency virus infection among adolescents attending three diverse clinics. J Pediatr. 1993 May; 122(5 Pt 1):813-20. Moscicki AB, Millstein SG, Broering J, Irwin CE. PMID: 8496769.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    59. Comparison between colposcopic, cytologic, and histologic findings in women positive and negative for human papillomavirus DNA. J Adolesc Health. 1993 Mar; 14(2):74-9. Moscicki AB, Broering J, Powell K, Klein J, Clayton L, Smith G, Boero S, Darragh TM, Brescia RJ, Palefsky J. PMID: 8386548.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    60. Childhood sexual learning and sex education in schools. NAACOGS Clin Issu Perinat Womens Health Nurs. 1991; 2(2):179-89. Broering JM. PMID: 2043415.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. Adolescent health care: a challenge for nursing educators. J Nurs Educ. 1988 Jun; 27(6):278-80. Panzarine S, Broering J, Gephart J, Lucas SE, Minas E, Savedra M, St Germaine A, Wildey L. PMID: 2837550.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Juvenile Status Offenders' Perceptions of Life Change Events. Psychiatric Annals. 1987; 12(17):818-821. Broering JM Irwin CE. View Publication.
    Jeanette's Networks
    Concepts (203)
    Derived automatically from this person's publications.
    _
    Co-Authors (39)
    People in Profiles who have published with this person.
    _
    Similar People (59)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _